Liberty Health Sciences Sees Strong Growth in Florida Cannabis Market

Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Liberty Health Sciences’ sales surge on explosive market growth in early 2018

Liberty receives approval for Florida distribution hub, bringing one-day delivery service commitment to southern Florida

TORONTO, April 11, 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) today announced that the Company has recorded a 253% increase in monthly revenue since the start of 2018, and a 100% increase in its served patient count. The surge has been fueled by unprecedented growth in the number of registered medical cannabis patients and physicians in the state of Florida. So far this year, the number of registered patients in Florida has increased 46% to over 93,000 patients, and the number of recommending physicians has increased 44% as the physician community continues to witness the benefits of medical cannabis first-hand.

The registered patient count in Florida is expected to continue to increase rapidly as more physicians recommend cannabis as a treatment option, and as more Florida residents become educated on the benefits of medical cannabis to treat certain qualifying conditions. The Florida Department of Health (“DOH”) continues to make progress in processing the high volume of applications and issuing Medical Marijuana Use Registry identification cards, which is also helping to accelerate demand for Liberty’s products throughout the state.

Our patient-centric approach has been very well received in Florida. Our Cannabis Education Centers, which we are continuing to roll-out across the state, provides comprehensive education, resources and compassionate one-on-one consultations geared towards educating patients on cannabis use as a safe treatment alternative to treat their symptoms.

George Scorsis, Director and CEO of Liberty

 Liberty is proud to provide Florida’s patients in need with convenient and timely access to high-quality, clean and safe pharmaceutical-grade medical cannabis when they need it the most.

In response to the rapidly growing patient demand, Liberty is expanding its home delivery model to bring 24-hour delivery service to patients across southern Florida. The Company has received approval from the DOH to establish a distribution center (“Hub”) located in Fort Lauderdale. Supported by a fleet of eco-friendly hybrid vehicles, The Hub will provide one-day delivery service to patients in Broward, Miami-Dade and Palm Beach counties, an area with nearly 6 million people representing 29% of the state’s population. Liberty is also expanding its fleet to provide one-day delivery service to patients in Alachua and Marion counties. This fast and convenient service will also be offered through Liberty’s Cannabis Education Centre in The Villages and at the Company’s future dispensary locations expected to open soon. In total the Company’s one-day delivery service will reach 6.6 million people, or 32% of Florida’s population.

“The growth in registered medical cannabis patients in Florida is far exceeding our expectations, but Liberty is fully prepared to meet the rapidly expanding demand with our production expansion currently underway at Chestnut Hill and Liberty 360 facilities and our new southern Florida distribution hub,” said Scorsis. “We are committed to providing all of our patients across Florida with fast and convenient access to medical cannabis, regardless of their location in the state.”

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit libertyhealthsciences.com

Original Press Release

The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter